1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial
| Autor: | Attard, G., Sandhu, S.K., Rathkopf, D., Castro, E., Saad, M., Smith, M.R., Small, E.J.J., Olmos, D., Gomes, A.J.P.D.S., Roubaud, G., Zurawski, B., Efstathiou, E., Wu, D., Diorio, B., Urtishak, K., Singh, U., Xu, Y., Lopez-Gitlitz, A., del Corral, A., Chi, K.N.N. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S976-S977 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|